Pay in 4 interest-free payments of $6.14 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
(8.1) CLINICAL PHARMACOLOGY : Mechanism of Action : Sitagliptin is a DPP-4 inhibitor, which is believed to exert its actions in patients with type 2 diabetes by slowing the inactivation of incretin hormones
)
This delay prolongs nutrient absorption and stabilizes post-meal glucose responses, reducing spikes that can contribute to fat accumulation and energy crashes
Tirzepatide activates GLP-1 receptors in the brain, which reduces the activity in the brain that controls appetite and increases the neuronal functions that control feelings of fullness
GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) deliver remarkable weight loss but create a critical nutritional challenge: maintaining adequate protein intake
FDA-registered National Drug Code All Flex Certified compounds have a FDA-registered NDC, unlike 503A drugs
US$ 28.63
US$ 23.27
US$ 24.93
